These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 27869062)

  • 1. Is the Polymyxin B Resistance Among Multidrug-Resistant Enterobacteriaceae (Except for the Carbapenemase-producing Ones) a Myth or a Matter?
    Perez LR
    Infect Control Hosp Epidemiol; 2017 Jan; 38(1):126-127. PubMed ID: 27869062
    [No Abstract]   [Full Text] [Related]  

  • 2. What's Lurking Around the Corner? Polymyxin B Resistance Among Klebsiella pnemoniae carbapenemase-producing Enterobacteriaceae, and Others, as a Burden of Use.
    Perez LRR
    Infect Control Hosp Epidemiol; 2017 Sep; 38(9):1120-1121. PubMed ID: 28693659
    [No Abstract]   [Full Text] [Related]  

  • 3. [Laboratory detection of carbapenemase-producing Enterobacteriaceae].
    Cercenado E
    Rev Esp Quimioter; 2015 Sep; 28 Suppl 1():8-11. PubMed ID: 26365726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Usefulness of piperacillin/tazobactam resistance as a predictor of OXA-48 carbapenemase in Enterobacteriaceae].
    Grados M; Fernández S; Lara N; Alós JI
    Rev Esp Quimioter; 2017 Aug; 30(4):299-300. PubMed ID: 28541011
    [No Abstract]   [Full Text] [Related]  

  • 5. Epidemiology of Adaptive and Intrinsic Polymyxin Resistance Mechanisms by Comparing Polymyxin-Resistant Pathogen Prevalence in a One-Year Follow-Up Survey.
    Perez LRR
    Infect Control Hosp Epidemiol; 2017 Sep; 38(9):1121-1123. PubMed ID: 28840792
    [No Abstract]   [Full Text] [Related]  

  • 6. Detection of Carbapenemase Production in a Collection of Enterobacteriaceae with Characterized Resistance Mechanisms from Clinical and Environmental Origins by Use of Both Carba NP and Blue-Carba Tests.
    García-Fernández S; Morosini MI; Gijón D; Beatobe L; Ruiz-Garbajosa P; Domínguez L; Cantón R; Valverde A
    J Clin Microbiol; 2016 Feb; 54(2):464-6. PubMed ID: 26607979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The challenges of carbapenemase-producing Enterobacteriaceae and infection prevention: protecting patients in the chaos.
    Savard P; Carroll KC; Wilson LE; Perl TM
    Infect Control Hosp Epidemiol; 2013 Jul; 34(7):730-9. PubMed ID: 23739078
    [No Abstract]   [Full Text] [Related]  

  • 8. Antimicrobial resistance 2010: global attention on carbapenemase-producing bacteria.
    ECDC Antimicrobial Resistance and Healthcare-Associated Infections Programme
    Euro Surveill; 2010 Nov; 15(46):. PubMed ID: 21144433
    [No Abstract]   [Full Text] [Related]  

  • 9. Over-treatment of carbapenemase-producing Enterobacteriaceae.
    Rihani DS; Wallace MR; Sieger BE; Waite RA; Fox M; Brown SA; Deryke CA
    Scand J Infect Dis; 2012 May; 44(5):325-9. PubMed ID: 22200121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NDM-1, OXA-48 and OXA-181 carbapenemase-producing Enterobacteriaceae in Sultanate of Oman.
    Dortet L; Poirel L; Al Yaqoubi F; Nordmann P
    Clin Microbiol Infect; 2012 May; 18(5):E144-8. PubMed ID: 22404169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro activity of tigecycline against metallo-beta-lactamase-producing Enterobacteriaceae.
    Pliatsika V; Afkou Z; Protonotariou E; Sofianou D
    J Antimicrob Chemother; 2007 Dec; 60(6):1406-7. PubMed ID: 17962216
    [No Abstract]   [Full Text] [Related]  

  • 12. Carbapenemase-producing Enterobacteriaceae: a call for action!
    Nordmann P; Cornaglia G
    Clin Microbiol Infect; 2012 May; 18(5):411-2. PubMed ID: 22507108
    [No Abstract]   [Full Text] [Related]  

  • 13. ESBL- and Carbapenemase-Producing Enterobacteriaceae in Patients with Bacteremia, Yangon, Myanmar, 2014.
    Myat TO; Hannaway RF; Zin KN; Htike WW; Win KK; Crump JA; Murdoch DR; Ussher JE
    Emerg Infect Dis; 2017 May; 23(5):857-859. PubMed ID: 28418298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial susceptibility patterns of KPC-producing or CTX-M-producing Enterobacteriaceae.
    Castanheira M; Sader HS; Jones RN
    Microb Drug Resist; 2010 Mar; 16(1):61-5. PubMed ID: 20192819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of phenotypic tests for detecting BKC-1-producing Enterobacteriaceae isolates.
    Martins WM; Cordeiro-Moura JR; Ramos AC; Fehlberg LC; Nicoletti AG; Gales AC
    Diagn Microbiol Infect Dis; 2016 Mar; 84(3):246-8. PubMed ID: 26744087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activity of polymyxin B plus imipenem, meropenem, or tigecycline against KPC-2-producing Enterobacteriaceae with high MICs for these antimicrobials.
    Barth N; Ribeiro VB; Zavascki AP
    Antimicrob Agents Chemother; 2015; 59(6):3596-7. PubMed ID: 25801560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for fecal carriage of carbapenemase producing Enterobacteriaceae among intensive care unit patients from a tertiary care center in India.
    Mittal G; Gaind R; Kumar D; Kaushik G; Gupta KB; Verma PK; Deb M
    BMC Microbiol; 2016 Jul; 16(1):138. PubMed ID: 27392139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fosfomycin: an oral agent for urinary infection caused by extended spectrum beta-lactamase producing organisms.
    Hutley EJ; Chand MA; Hounsome G; Kelsey MC
    J Infect; 2010 Apr; 60(4):308-9. PubMed ID: 20114062
    [No Abstract]   [Full Text] [Related]  

  • 19. Carbapenemase-producing enterobacteriaceae (CPE) in the pediatric setting: results from an 18-month survey.
    Colombo S; Scolfaro C; Calitri C; Denina M; Carraro F; De Intinis G; Tovo PA
    Infect Control Hosp Epidemiol; 2014 May; 35(5):599-601. PubMed ID: 24709738
    [No Abstract]   [Full Text] [Related]  

  • 20. New Delhi metallo beta-lactamase: what is in a name?
    Nataraj G
    J Postgrad Med; 2010; 56(4):251-2. PubMed ID: 20935391
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.